David García-Dorado Selected Research

4,17 beta-dihydroxy-4-androstene-3-one

5/2013	Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
12/2011	Effects of a reduction in the number of gap junction channels or in their conductance on ischemia-reperfusion arrhythmias in isolated mouse hearts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David García-Dorado Research Topics

Disease

16	Infarction (Infarctions) 01/2021 - 04/2003
11	Myocardial Infarction 01/2021 - 07/2011
9	Ischemia 01/2018 - 04/2003
8	Atrial Fibrillation 06/2019 - 10/2013
8	Reperfusion Injury 01/2018 - 07/2003
7	Hemorrhage 05/2019 - 09/2010
6	ST Elevation Myocardial Infarction 01/2021 - 02/2013
6	Thrombosis (Thrombus) 01/2019 - 11/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 06/2011
5	Hypertrophy 01/2018 - 10/2011
4	Marfan Syndrome (Marfan's Syndrome) 10/2018 - 06/2011
4	Cardiomegaly (Heart Hypertrophy) 01/2018 - 10/2011
3	Stroke (Strokes) 01/2019 - 11/2011
3	Cardiomyopathies (Cardiomyopathy) 06/2018 - 02/2010
3	Coronary Occlusion 01/2018 - 09/2005
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2014 - 04/2003
3	Hypoxia (Hypoxemia) 12/2008 - 03/2005
2	Fibrosis (Cirrhosis) 10/2020 - 10/2013
2	Acute Coronary Syndrome 05/2020 - 11/2011
2	Pericarditis 09/2019 - 12/2015
2	Bundle-Branch Block (Fascicular Block) 01/2019 - 01/2019
2	Heart Failure 01/2018 - 01/2017
2	Ventricular Fibrillation 04/2017 - 11/2009
2	Thromboembolism 01/2016 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 02/2012 - 04/2009
2	Rupture 06/2011 - 03/2005
2	Acidosis 12/2008 - 03/2005
1	Diabetes Mellitus 05/2020
1	Dyslipidemias (Dyslipidemia) 05/2020
1	Overweight 05/2020
1	Heart Arrest (Cardiac Arrest) 03/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 09/2019
1	Death (Near-Death Experience) 01/2019
1	Syncope (Fainting) 01/2019
1	Aortic Valve Stenosis (Aortic Stenosis) 09/2018
1	Left Ventricular Dysfunction 06/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2017
1	Shock 04/2017
1	Bicuspid Aortic Valve Disease 01/2017

Drug/Important Bio-Agent (IBA)

4	Connexin 43 (Connexin43)IBA 01/2018 - 09/2005
3	LipidsIBA 05/2020 - 01/2016
3	omega-Chloroacetophenone (Mace)IBA 05/2019 - 06/2011
3	malonic acid (malonate)IBA 04/2019 - 03/2016
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 04/2019 - 03/2016
3	CalciumIBA 01/2019 - 01/2015
3	Atenolol (Tenormin)FDA LinkGeneric 10/2018 - 06/2011
3	Losartan (Cozaar)FDA LinkGeneric 10/2018 - 06/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 10/2011
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2016 - 10/2013
3	Diazoxide (Hyperstat)FDA Link 05/2013 - 09/2005
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 09/2008
2	Pharmaceutical PreparationsIBA 01/2019 - 10/2010
2	endonuclease GIBA 01/2018 - 10/2011
2	P-SelectinIBA 09/2017 - 01/2016
2	FibrinIBA 09/2017 - 01/2016
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2017 - 03/2005
2	Angiotensin IIIBA 01/2017 - 03/2012
2	Biomarkers (Surrogate Marker)IBA 03/2014 - 09/2008
2	4,17 beta-dihydroxy-4-androstene-3-oneIBA 05/2013 - 12/2011
2	Atropine FDA LinkGeneric 02/2013 - 10/2010
2	Dobutamine FDA LinkGeneric 07/2011 - 02/2010
2	Heptanol (1 Heptanol)IBA 02/2006 - 08/2004
1	Exenatide (Byetta)FDA Link 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 10/2020
1	Matrix Metalloproteinases (MMPs)IBA 10/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2020
1	LDL CholesterolIBA 05/2020
1	oxidized low density lipoproteinIBA 05/2020
1	Phosphopyruvate Hydratase (Enolase)IBA 03/2020
1	Colchicine FDA LinkGeneric 09/2019
1	Procainamide (Procan)FDA LinkGeneric 01/2019
1	Vitamin K FDA Link 01/2019
1	N(4)-oleylcytosine arabinosideIBA 01/2019
1	Flecainide (Tambocor)FDA LinkGeneric 01/2019
1	Mineralocorticoid Receptor AntagonistsIBA 01/2018
1	humaninIBA 01/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2018
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018
1	IvabradineIBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	Air Pollutants (Pollutants, Air)IBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	5- (6'- triphenylphosphoniumhexyl)- 5,6- dihydro- 6- phenyl- 3,8- phenanthridinediammineIBA 01/2018
1	Succinic Acid (Succinate)IBA 11/2017
1	Plasminogen Activator Inhibitor 1IBA 09/2017
1	Dialysis SolutionsIBA 01/2017
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2017

Therapy/Procedure

14	Therapeutics 01/2021 - 10/2012
11	Percutaneous Coronary Intervention 01/2021 - 11/2011
3	Secondary Prevention 05/2020 - 06/2015
3	Stents 01/2019 - 11/2011
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2018 - 06/2015
3	Drug-Eluting Stents 08/2015 - 09/2010
2	Induced Hypothermia 03/2020 - 09/2008
2	Defibrillators (Defibrillator) 06/2018 - 06/2015
2	Ischemic Postconditioning 11/2009 - 02/2009
1	Transcatheter Aortic Valve Replacement 09/2018
1	Cardiac Resynchronization Therapy 06/2018
1	Catheters 06/2017